Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Rothenfusser

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
Cancer Research|October 4, 2015
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progressionDavid Anz, Moritz Rapp, Stephan Eiber, et al.
Hepatology (Baltimore, Md.)|August 19, 2014
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virusFranziska S Hoffmann, Andreas Schmidt, Meike Dittmann Chevillotte, et al.
Leukemia|November 20, 2019
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockadeMichael Ruzicka, Lars M Koenig, Simone Formisano, et al.
International Archives of Allergy and Immunology|February 13, 2008
Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndromeMehdi Yeganeh, Philipp Henneke, Nima Rezaei, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Science Immunology|July 17, 2021
OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosisDaniel F R Boehmer, Simone Formisano, Carina C de Oliveira Mann, et al.
Molecular Cancer Therapeutics|June 25, 2026
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma modelCharlotte Marx, Julia Teppert, Laura Marisch, et al.
Nature Communications|February 24, 2024
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infectionAntonio Santos-Peral, Fabian Luppa, Sebastian Goresch, et al.
European Journal of Immunology|November 20, 2022
Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID-19 and after yellow fever vaccinationElena Winheim, Tabea Eser, Flora Deák, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
Cancer Research|October 4, 2015
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progressionDavid Anz, Moritz Rapp, Stephan Eiber, et al.
Hepatology (Baltimore, Md.)|August 19, 2014
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virusFranziska S Hoffmann, Andreas Schmidt, Meike Dittmann Chevillotte, et al.
Leukemia|November 20, 2019
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockadeMichael Ruzicka, Lars M Koenig, Simone Formisano, et al.
International Archives of Allergy and Immunology|February 13, 2008
Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndromeMehdi Yeganeh, Philipp Henneke, Nima Rezaei, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Science Immunology|July 17, 2021
OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosisDaniel F R Boehmer, Simone Formisano, Carina C de Oliveira Mann, et al.
Molecular Cancer Therapeutics|June 25, 2026
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma modelCharlotte Marx, Julia Teppert, Laura Marisch, et al.
Nature Communications|February 24, 2024
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infectionAntonio Santos-Peral, Fabian Luppa, Sebastian Goresch, et al.
European Journal of Immunology|November 20, 2022
Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID-19 and after yellow fever vaccinationElena Winheim, Tabea Eser, Flora Deák, et al.
Pageof 7